文献速递膀胱癌与上尿路尿路上皮癌

膀胱影像报告和数据系统对肌层浸润性膀胱癌的诊断准确性与观察者间一致性:一项多读者验证研究

Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
PubMed 文献 · Eur Urol · 2019-03-26

本研究回顾性纳入2010年1月至2018年8月单中心74例膀胱癌患者,评估VI-RADS对肌层浸润性膀胱癌的观察者间一致性和诊断性能。五位读者采用VI-RADS评分,观察者间一致性优秀(ICC 0.85,95%CI 0.80-0.89),诊断性能汇总AUC为0.90(95%CI 0.87-0.93)。

要点

  • 五位读者间VI-RADS评分一致性优秀,ICC为0.85(95%CI 0.80-0.89)。
  • VI-RADS诊断肌层浸润性膀胱癌的汇总AUC为0.90(95%CI 0.87-0.93)。
  • VI-RADS可作为膀胱癌患者制定合适治疗计划的综合工具。

核心结论

  • VI-RADS在五位读者间显示优秀的观察者间一致性,并对肌层浸润性膀胱癌具有良好诊断性能。
  • 作者认为VI-RADS适合作为膀胱癌患者制定合适治疗计划的综合工具。

研究设计与样本

  • 回顾性评估单中心2010年1月至2018年8月74例连续膀胱癌患者,均在经尿道电切术前接受多参数磁共振成像(mp-MRI)。
  • 五位读者使用VI-RADS评分评估肌层浸润性膀胱癌存在的概率。
  • 采用组内相关系数(ICC)评估观察者间一致性,采用受试者工作特征(ROC)分析评估诊断性能,对等级评分评估曲线下面积(AUC)。

主要发现

  • 五位读者间观察者间一致性优秀,ICC为0.85(95%置信区间0.80-0.89)。
  • VI-RADS诊断肌层浸润性膀胱癌的汇总AUC为0.90(95%置信区间0.87-0.93)。

临床怎么用

  • 作者认为VI-RADS适合作为膀胱癌患者制定合适治疗计划的综合工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A Vesical Imaging-Reporting and Data System (VI-RADS) based on multiparametric magnetic resonance imaging (mp-MRI) was developed to provide accurate information for the diagnosis of muscle-invasive bladder cancers (MIBCs). In this study we evaluated the interobserver agreement and diagnostic performance of VI-RADS. We retrospectively evaluated data for 74 consecutive patients with bladder cancer who had undergone mp-MRI before transurethral resection in a single institution from January 2010 to August 2018. Five readers assessed the probability of the presence of MIBC using VI-RADS scores. The interobserver agreement was assessed by measuring intraclass correlation coefficients (ICCs). Receiver operating characteristic (ROC) analysis was used to evaluate the MIBC diagnostic performance. The area under the ROC curve (AUC) was estimated for ordinal score assessments. Our study demonstrated that interobserver agreement was excellent among five readers (ICC 0.85, 95% confidence interval 0.80-0.89) and the diagnostic performance of VI-RADS was represented as a pooled AUC of 0.90 (95% confidence interval 0.87-0.93). PATIENT SUMMARY: We evaluated the interobserver agreement and diagnostic performance of a new scoring system based on magnetic resonance imaging called a Vesical Imaging-Reporting and Data System (VI-RADS) for muscle-invasive bladder cancer. Our results indicate that VI-RADS is suitable as a comprehensive tool for appropriate treatment planning for patients with bladder cancer.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Ueno Y, Takeuchi M, Tamada T, et al. Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study. Eur Urol. 2019. PMID: 30922688. doi:10.1016/j.eururo.2019.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。